Antonio Giordano: Sharon Burk has completed her PhD on The Role of Cyclin Dependent Kinase 10 in Triple Negative Breast Cancer
Antonio Giordano, President at Sbarro Health Research Organization, shared a post on LinkedIn:
“Today, we celebrate an incredible achievement – Sharon Burk has successfully completed her PhD with groundbreaking research on The Role of Cyclin Dependent Kinase 10 in Triple Negative Breast Cancer. Her dedication, intellect, and passion for science have been truly inspiring.
Sharon is a brilliant young scientist with a bright future ahead, and we have no doubt that she will make a lasting impact in the field. It has been an honor to witness her journey, and we are so proud of everything she has accomplished.
Wishing her all the success and opportunities she deserves!
Let’s all take a moment to recognize this incredible milestone – please join us in celebrating her achievement.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023